Protease inhibitors – Part 5. Alkyl/arylsulfonyl- and arylsulfonylureido-/arylureido- glycine hydroxamate inhibitors of Clostridium histolyticum collagenase

ChemInform Abstract: Protease Inhibitors: Synthesis of Clostridium histolyticum Collagenase Inhibitors Incorporating Sulfonyl-L-alanine Hydroxamate Moieties.

ChemInform ◽

10.1002/chin.200028194 ◽

2010 ◽

Vol 31 (28) ◽

pp. no-no

Author(s):

Andrea Scozzafava ◽

Claudiu T. Supuran

Keyword(s):

Protease Inhibitors ◽

ChemInform Abstract: Protease Inhibitors. Part 5. Alkyl/Arylsulfonyl- and Arylsulfonylureido-/Arylureido- Glycine Hydroxamate Inhibitors of Clostridium histolyticum Collagenase.

ChemInform ◽

10.1002/chin.200030182 ◽

2010 ◽

Vol 31 (30) ◽

pp. no-no

Author(s):

Andrea Scozzafava ◽

Claudiu T. Supuran

Keyword(s):

Protease Inhibitors ◽

Protease inhibitors. Part 8: synthesis of potent Clostridium histolyticum collagenase inhibitors incorporating sulfonylated l -alanine hydroxamate moieties

Bioorganic & Medicinal Chemistry ◽

10.1016/s0968-0896(99)00316-8 ◽

2000 ◽

Vol 8 (3) ◽

pp. 637-645 ◽

Cited By ~ 17

Author(s):

Andrea Scozzafava ◽

Claudiu T. Supuran

Keyword(s):

Protease Inhibitors ◽

Protease inhibitors: synthesis of Clostridium histolyticum collagenase inhibitors incorporating sulfonyl-l-alanine hydroxamate moieties

Bioorganic & Medicinal Chemistry Letters ◽

10.1016/s0960-894x(00)00026-3 ◽

2000 ◽

Vol 10 (5) ◽

pp. 499-502 ◽

Cited By ~ 20

Author(s):

Andrea Scozzafava ◽

Claudiu T Supuran

Keyword(s):

Protease Inhibitors ◽

Different roles of class I and class II Clostridium histolyticum collagenase in rat pancreatic islet isolation

Diabetes ◽

10.2337/diabetes.44.2.227 ◽

1995 ◽

Vol 44 (2) ◽

pp. 227-233 ◽

Cited By ~ 13

Author(s):

G. H. Wolters ◽

G. H. Vos-Scheperkeuter ◽

H. C. Lin ◽

R. van Schilfgaarde

Keyword(s):

Pancreatic Islet ◽

Class Ii ◽

Class I ◽

Islet Isolation ◽

Pancreatic Islet Isolation ◽

Clostridium Histolyticum Collagenase ◽

Rat Pancreatic Islet

Treatment of Dupuytren's disease using one full dose of Clostridium histolyticum collagenase at a lower concentration: Retrospective analysis of clinical outcomes

Hand Surgery and Rehabilitation ◽

10.1016/j.hansur.2020.02.012 ◽

2020 ◽

Vol 39 (4) ◽

pp. 316-319

Author(s):

Y. Goubau ◽

B. Vanmierlo ◽

C.-K. Goorens ◽

J.F. Goubau

Keyword(s):

Retrospective Analysis ◽

Clinical Outcomes ◽

Dupuytren’S Disease ◽

Dupuytren's Disease ◽

Full Dose ◽

The Impact of Clostridium Histolyticum Collagenase on the Prevalence and Management of Peyronie's Disease in the United States

The World Journal of Men s Health ◽

10.5534/wjmh.180073 ◽

2019 ◽

Vol 37 (2) ◽

pp. 234 ◽

Cited By ~ 8

Author(s):

Andrew J. Sun ◽

Shufeng Li ◽

Michael L. Eisenberg

Keyword(s):

United States ◽

The United States ◽

Peyronie’S Disease ◽

Clostridium Histolyticum Collagenase ◽

Peyronie's Disease ◽

The Impact

Inhibition of Clostridium histolyticum supernatant cytotoxic activity by protease inhibitors

Enzyme and Microbial Technology ◽

10.1016/j.enzmictec.2005.09.002 ◽

2006 ◽

Vol 39 (1) ◽

pp. 28-31 ◽

Cited By ~ 3

Author(s):

Jarosław Jóźwiak ◽

Aldona Komar ◽

Ewa Jankowska ◽

Gayane Martirosian

Keyword(s):

Cytotoxic Activity ◽

Protease Inhibitors ◽

Clostridium Histolyticum

New thiol inhibitors of Clostridium histolyticum collagenase. Importance of the P3' position

European Journal of Biochemistry ◽

10.1111/j.1432-1033.1988.tb13955.x ◽

1988 ◽

Vol 172 (3) ◽

pp. 764-766

Author(s):

Athanasios YIOTAKIS ◽

Athina HATGIYANNACOU ◽

Vincent DIVE ◽

Flavio TOMA

Keyword(s):

pH in the Bacteria-Contaminated Wound and Its Impact on Clostridium histolyticum Collagenase Activity

Journal of Wound Ostomy and Continence Nursing ◽

10.1097/won.0b013e31822ad034 ◽

2011 ◽

Vol 38 (5) ◽

pp. 514-521 ◽

Cited By ~ 22

Author(s):

Lei Shi ◽

Sarah Ramsay ◽

Ryan Ermis ◽

Dennis Carson

Keyword(s):

Collagenase Activity ◽

Clostridium Histolyticum Collagenase ◽

Contaminated Wound